Author: R.J. Hay
Authoritative and richly illustrated, this clinical text covers the use of oral terbinafine (Lamisil) as first-line therapy for onychomycosis (fungal nail infections) and as a rational choice for fungal skin infections that require oral therapy. Author Doctor R.J. Hay comprehensively reviews the data on Lamisil, presenting much of it in tables for easy access. He covers pharmacology and pharmacokinetics and the use of Lamisil tablets in onychomycosis, tinea capitis, dermatomycoses, subcutaneous and systemic mycoses, and
other infectious diseases. Dr. Hay discusses the safety and tolerability of Lamisil tablets, including the
postmarketing surveillance study and interactions with other drugs.
